Trial reportDiabetes, obesity & metabolism2025
Comparative efficacy of sleeve gastrectomy with fundoplication versus standard sleeve gastrectomy in obesity and gastroesophageal reflux disease: A randomised trial.
Trial report in Diabetes, obesity & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Comparative efficacy of sleeve gastrectomy with fundoplication versus standard sleeve gastrectomy in obesity and gastroesophageal reflux disease: A randomised trial.Diabetes, obesity & metabolism · 2025Trial
- Weight loss outcomes after Nissen sleeve gastrectomy vs standard sleeve gastrectomy in female patients: a retrospective matched -cohort study.Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques · 2026Article
- Preoperative Hill grade versus hiatal hernia size: which drives the decision for Dor fundoplication during sleeve gastrectomy? A retrospective cohort study.Frontiers in surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
aimsThis randomised controlled trial compared the efficacy of modified laparoscopic sleeve gastrectomy with fundoplication (LSGFD) versus standard laparoscopic sleeve gastrectomy (LSG) in achieving weight loss and alleviating gastroesophageal reflux disease (GERD) in patients with obesity. MATERIALS AND
methodsEighty patients with obesity (body mass index [BMI] ≥27.5 kg/m
resultsNo significant differences were observed between the two groups in preoperative parameters. However, at 6 and 12 months postoperatively, both groups showed significant reductions in body weight, BMI, waist circumference, hip circumference and waist-hip ratio, along with a significant increase in the %EWL. The LSGFD group demonstrated superior outcomes in treating GERD and other obesity-related comorbidities, particularly notable improvements in reflux esophagitis.
conclusionsLSGFD provides equivalent weight loss to LSG but significantly superior control of GERD symptoms and resolution of reflux esophagitis. It offers enhanced management of obesity-related comorbidities without increasing surgical risk, supporting its use in obese patients with GERD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.